Diligence memo · auto-generated · as of July 2, 2026

Meridian Biotech, LLC

Meridian Biotech, LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Meridian Biotech, LLC operates in Biotech, based in THE WOODLANDS.

Sub-sector tags: biotech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Meridian Biotech, LLC has raised $3.9M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.2M on 2020-09-16.

Most recent recorded round closed around 2020-09-16.

Valuation (modeled)modeled

Provath models Meridian Biotech, LLC at approximately $88M (range $1.6M–$653M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Seed Biotech companies in 2019–2021 (7 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 5.8 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 78% of Biotech peers (233 compared).

Modeled value ranks above 87% of those peers.

Closest niche peers: Orpheus Bioscience, Inc., OneThree Biotech, Inc., Phloem Biotech, Inc., Sixfold Bioscience Inc., iGenomX International Genomics Corp.

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.